My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Perrigo (NY:PRGO)

13.49 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Dec 4, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Perrigo

< Previous 1 2 3 4 5 6 Next >

FDA Sets New Adcomm Date To Review Perrigo's Oral Contraceptive Pill For OTC Use ↗

March 28, 2023

Via Benzinga

Republicans Seek Documents, Schedule Hearing Related To FDA's Response To Baby-Formula Shortage ↗

March 21, 2023

House Republicans are reportedly speeding up their scrutiny of the FDA and the White House's handling of the baby formula shortage last year.

Via Benzinga

Insiders Selling Perrigo And 3 Other Stocks ↗

March 10, 2023

The Nasdaq Composite dropped by around 2% on Thursday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023 ↗

March 07, 2023

Via Benzinga

Earnings Outlook For Perrigo Co ↗

February 24, 2023

Via Benzinga

Why Perrigo Stock Tanked on Tuesday ↗

November 08, 2022

A double miss and a guidance cut badly affected investor sentiment.

Via The Motley Fool

FDA Postpones Review Meeting For First OTC Contraceptive Option From Perrigo ↗

October 26, 2022

Via Benzinga

Earnings Scheduled For February 27, 2023 ↗

February 27, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million.

Via Benzinga

Perrigo Shares Pop On Raised FY22 Guidance Surpassing Consensus Estimates ↗

May 11, 2022

Via Benzinga

7 Perfect Presents to Gift Your 2023 Stock Portfolio ↗

December 21, 2022

As we leave 2022 behind, these hot stocks to buy have significant potential and serious catalysts as we move into New Year 2023.

Via InvestorPlace

SWEDEN’S SKINCARE SENSATION ACO EXTENDS PRESENCE INTO US TIMED TO THE HOLIDAY SEASON

December 16, 2022

Stolkholm’s Best Kept Skincare Secret Is The Perfect Gift For Giving

From ACO

Via GlobeNewswire

Perrigo, Tripadvisor, Lyft, And Some Other Big Stocks Moving Lower On Tuesday ↗

November 08, 2022

U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Earnings Scheduled For May 11, 2022 ↗

May 11, 2022

Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.

Via Benzinga

Earnings Scheduled For March 1, 2022 ↗

March 01, 2022

Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...

Via Benzinga

Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday ↗

November 09, 2022

Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday.

Via Benzinga

Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session ↗

November 08, 2022

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast...

Via Benzinga

Perrigo Shares Fall As Investors React To Lowered FY22 Profit Guidance ↗

November 08, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022 ↗

September 14, 2022

Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low...

Via Benzinga

FDA Schedules AdComm Review For First Over The Counter Birth Control Pill ↗

September 13, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2022 ↗

September 06, 2022

Upgrades

Via Benzinga

Is Sanofi A Buy, Despite Recent Stumbles?

August 19, 2022

Pharmaceuticals are subject to whiplash trade. That's evident with sharp moves lower in Sanofi, GSK and Teva on news about clinical trials and legal actions.

Via MarketBeat

Topics Intellectual Property

Earnings Scheduled For August 9, 2022 ↗

August 09, 2022

Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.

Via Benzinga

Perrigo Stock Mystery; Big Money Loves It, Though Profits Slim ↗

July 12, 2022

Institutional investors like mutual funds can't get enough of Perrigo stock. It has an A Accumulation/Distribution Rating.

Via Investor's Business Daily

Perrigo Seeks FDA Approval For the First OTC Contraceptive Pill ↗

July 11, 2022

Perrigo Company plc's (NYSE: PRGO) HRA Pharma has

Via Benzinga

The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death ↗

July 11, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

This $5B Pharmaceutical Could Benefit From Over-The-Counter Contraceptives And Plan B Alternatives ↗

June 27, 2022

The ruling by the U.S. Supreme Court to overturn Roe v. Wade and leave the decision of abortion to the states has been a big topic over the last few days. An analyst singles out a pharmaceutical...

Via Benzinga

Bette Midler Panned For Breastfeeding Remark In Wake Of Baby Formula Shortage ↗

May 16, 2022

Singer and actress Bette Midler received a round of boos on Twitter Inc (NYSE: TWTR) after volunteering the idea that American women impacted by the ongoing baby formula shortage turn to...

Via Benzinga

Cannabis Movers & Shakers: MedMen's New CEO, TerrAscend, FoliuMed, Charlotte's Web & Proof Announce Appointments ↗

April 29, 2022

MedMen Names New CEO Cannabis retailer MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) has appointed a new CEO, Edward Record, who has been serving on the company's board since 2021.

Via Benzinga

Perrigo: Q4 Earnings Insights ↗

March 01, 2022

Perrigo (NYSE:PRGO) reported its Q4 earnings results on Tuesday, March 1, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings Perrigo...

Via Benzinga

Daily Report: Perrigo (PRGO) ↗

February 09, 2022

Perrigo's price per share was $37.54 as of yesterday's market close. One year ago its price was $43.09.

Via Talk Markets

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.